PEDIATRICS Vol. 36 No. 2 August 1965, pp. 251-256
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parrish, H. M.
Right arrow Articles by Silberg, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parrish, H. M.
Right arrow Articles by Silberg, S. L.

COMPARISON BETWEEN SNAKEBITES IN CHILDREN AND ADULTS

Henry M. Parrish M.D., Dr.P.H.1, John C. Goldner M.D.1, and Stanley L. Silberg M.A., M.P.H.1

1 Department of Community Health and Medical Practice, School of Medicine, University of Missouri, Columbia, Missouri

This study is based on the hospital records of 1,538 people bitten by poisonous snakes during 1958 and 1959 in 10 selected states having high snakebite rates. Of these, 792 were less than 20 years of age and 746 were 20 or more years of age.

Snakebite rates were highest among children 5-19 years of age. Males had higher rates than females and whites had higher rates than non-whites. Children were not found to have excessively high case-fatality rates.

Ninety-five percent of the snakebites happened from April through October. Ninety-seven percent of the bites were inflicted on the extremities: 34% on the upper extremities and 63% on the lower extremities.

For 1,078 cases where antivenin was administered there were three deaths—a case-fatality rate of 0.28%. These patients received insufficient doses of antivenin. In 460 cases where there was no antivenin given there were 12 deaths—a case-fatality rate of 2.61%. These differences were statistically significant. The actual doses of antivenin which produced these results are listed.

Submitted on December 10, 1964
Accepted on March 18, 1965




This article has been cited by other articles:


Home page
 PediatricsHome page
S. R. Offerman, S. P. Bush, J. A. Moynihan, and R. F. Clark
Crotaline Fab Antivenom for the Treatment of Children With Rattlesnake Envenomation
Pediatrics, November 1, 2002; 110(5): 968 - 971.
[Abstract] [Full Text] [PDF]